Advertisement
Advertisement

IMRX

IMRX logo

Immuneering Corporation Class A Common Stock

5.38
USD
Sponsored
+0.20
+3.86%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

5.35

-0.03
-0.56%

Immuneering Corporation Class A Common Stock Profile

About

Immuneering Corporation is a biopharmaceutical company advancing a pipeline of oncology and neuroscience product candidates. The company's product candidate includes IMM-1-104. Immuneering Corporation is based in CAMBRIDGE, Mass.

Info & Links

CEO

Benjamin J. Zeskind

Headquarters

245 MAIN STREET, SECOND FLOOR
CAMBRIDGE, MA 02142, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.immuneering.com

Auditor

RSM US LLP

Share holders

60

Employees

53

Immuneering Corporation Class A Common Stock Statistics

Valuation Measures

Market Capitalization2

346.13M

Enterprise Value

217.49M

Enterprise Value/EBITDA(ttm)

-3.70

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.67

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-43.33%

Return on Invested Capital(ttm)

-97.70%

Return on Assets(ttm)

-39.75%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-58.83M

Net Income Available to Common(ttm)

-56.02M

Diluted EPS(ttm)

-1.38

Share Statistics

Beta (5Y Monthly)

0.43

52-Week Change

320.31%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

64.65M

Dividend Yield

0.00%

Float4

49.85M

% Held by Insiders

22.90%

% Held by Institutions

67.65%

Balance Sheet

Total Cash(mrq)

172.83M

Total Cash Per Share(mrq)

2.67

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

17.50%

Quick Ratio(mrq)

17.50%

Book Value Per Share(mrq)

3.38

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.03

Free Cash Flow(ytd)

-45.49M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement